Assyro AI

Orange Book product · Generic (ANDA)

TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Generic (ANDA)ANDA 214008TE ABRX NATCO

At a glance

Jun 13, 2023

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 13, 2023

    3 yr 1 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Strength

EQ 6.14MG BASE;15MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 214008

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.